Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists

por Rebordosa, Cristina, Plana, Estel, Rubino, Annalisa, Aguado, Jaume, Martinez, David, Lei, Alejhandra, Daoud, Sami, Saigi-Morgui, Nuria, Perez-Gutthann, Susana, Rivero-Ferrer, Elena
Publicado 2022

Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Prima...

por Requena, Gema, Banks, Victoria, Czira, Alexandrosz, Wood, Robert, Tritton, Theo, Wild, Rosie, Compton, Chris, Duarte, Maria, Ismaila, Afisi S
Publicado 2022

The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective

por Gunen, Hakan, Kokturk, Nurdan, Naycı, Sibel, Ozkaya, Sevket, Yıldız, Birsen Pınar, Turan, Onur, Gumus, Aziz, Akgun, Metin, Gurgun, Alev, Ogus, Candan, Mirici, Arzu, Sen, Elif, Bayram, Nazan, Eken, Volkan, Erkus, Hakan
Publicado 2022

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain

por Neches García, Victoria, Vallejo-Aparicio, Laura Amanda, Ismaila, Afisi S, Sicras-Mainar, Antoni, Sicras-Navarro, Aram, González, Cruz, Cuervo, Rafael, Shukla, Soham, García-Peñuela, Marcos
Publicado 2022

Circ_0040929 Serves as Promising Biomarker and Potential Target for Chronic Obstructive Pulmonary Disease

por Miao, Yi, Wu, Junfang, Wu, Runmiao, Wang, Enguang, Wang, Jing
Publicado 2022

Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD

por Lee, Hyo Jin, Jin, Kwang Nam, Lee, Hyun Woo, Lee, Jung-Kyu, Park, Tae Yeon, Heo, Eun Young, Kim, Deog Kyeom
Publicado 2022

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis

por Buhl, Roland, Wilke, Thomas, Picker, Nils, Schmidt, Olaf, Hechtner, Marlene, Kondla, Anke, Maywald, Ulf, Vogelmeier, Claus F
Publicado 2022

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs

por Leving, Marika T, van Boven, Job F M, Bosnic-Anticevich, Sinthia Z, van Cooten, Joyce, Correia de Sousa, Jaime, Cvetkovski, Biljana, Dekhuijzen, Richard, Dijk, Lars, García Pardo, Marina, Gardev, Asparuh, Gawlik, Radosław, van der Ham, Iris, Hartgers-Gubbels, Elisabeth Sophia, Janse, Ymke, Lavorini, Federico, Maricoto, Tiago, Meijer, Jiska, Metz, Boyd, Price, David B, Roman-Rodríguez, Miguel, Schuttel, Kirsten, Stoker, Nilouq, Tsiligianni, Ioanna, Usmani, Omar S, Kocks, Janwillem H
Publicado 2022

Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease

por Chen, Guohuan, Lin, Qingyu, Zhuo, Debin, Cui, Jinhe
Publicado 2022

Disability Retirement After First Admission with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Danish Nationwide Registry Cohort Study Using a Retrospective Follow...

por Jacobsen, Peter Ascanius, Kragholm, Kristian, Torp-Pedersen, Christian, Møller Weinreich, Ulla
Publicado 2022

Superior Predictive Value of D-Dimer to the Padua Prediction Score for Venous Thromboembolism in Inpatients with AECOPD: A Multicenter Cohort Study

por Zhou, Chen, Guang, Yujie, Luo, Yuanming, Ge, Huiqing, Wei, Hailong, Liu, Huiguo, Zhang, Jianchu, Pan, Pinhua, Zhang, Jiarui, Peng, Lige, Aili, Adila, Liu, Yu, Pu, Jiaqi, Zhong, Xia, Wang, Yixi, Yi, Qun, Zhou, Haixia
Publicado 2022

Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial

por Halpin, David M G, Kendall, Robyn, Shukla, Soham, Martin, Alan, Shah, Dhvani, Midwinter, Dawn, Beeh, Kai M, Kocks, Janwillem W H, Jones, Paul W, Compton, Chris, Risebrough, Nancy A, Ismaila, Afisi S
Publicado 2022

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Dis...

por de Nigris, Enrico, Treharne, Catrin, Brighton, Nick, Holmgren, Ulf, Walker, Andrew, Haughney, John
Publicado 2022

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc A...

por Bafadhel, Mona, Rabe, Klaus F, Martinez, Fernando J, Singh, Dave, Darken, Patrick, Jenkins, Martin, Aurivillius, Magnus, Patel, Mehul, Dorinsky, Paul
Publicado 2022

Breathing Exercises in the Treatment of COPD: An Overview of Systematic Reviews

por Li, Yiting, Ji, Zile, Wang, Yan, Li, Xuanlin, Xie, Yang
Publicado 2022

Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acti...

por Requena, Gema, Banks, Victoria, Czira, Alexandrosz, Wood, Robert, Tritton, Theo, Wild, Rosie, Compton, Chris, Ismaila, Afisi S
Publicado 2023

Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care...

por Czira, Alexandrosz, Requena, Gema, Banks, Victoria, Wood, Robert, Tritton, Theo, Castillo, Catherine M, Yeap, Jie, Wild, Rosie, Compton, Chris, Rothnie, Kieran J, Herth, Felix, Quint, Jennifer K, Ismaila, Afisi S
Publicado 2023

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of...

por Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Gates, Davis, Staudinger, Heribert
Publicado 2012

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation

por Kitaguchi, Yoshiaki, Yasuo, Masanori, Hanaoka, Masayuki
Publicado 2016

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

por Rodrigo, Gustavo J, Price, David, Anzueto, Antonio, Singh, Dave, Altman, Pablo, Bader, Giovanni, Patalano, Francesco, Fogel, Robert, Kostikas, Konstantinos
Publicado 2017